Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001415889-25-010779
Filing Date
2025-04-16
Accepted
2025-04-16 11:20:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5299
  Complete submission text file 0001415889-25-010779.txt   7082
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Subject) CIK: 0000059478 (see all company filings)

EIN.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-17885 | Film No.: 25841677
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2801 NORTH MERIDIAN ST INDIANAPOLIS IN 46208
Business Address 2801 NORTH MERIDIAN STREET INDIANANAPOLIS IN 46208 3179245471
LILLY ENDOWMENT INC (Filed by) CIK: 0000316011 (see all company filings)

EIN.: 350868122 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SCHEDULE 13G/A